A Study to Evaluate the Effect of Saroglitazar Magnesium on the QTc Interval in Healthy Volunteers
Clinical trial NCT04045769 · COMPLETED
Trial details
- NCT number
- NCT04045769
- Sponsor
- Zydus Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-19
- Primary completion
- 2019-11-27
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.